NZ201685A - Pharmaceutical compositions comprising human insulin,human c-peptide and human proinsulin - Google Patents

Pharmaceutical compositions comprising human insulin,human c-peptide and human proinsulin

Info

Publication number
NZ201685A
NZ201685A NZ201685A NZ20168582A NZ201685A NZ 201685 A NZ201685 A NZ 201685A NZ 201685 A NZ201685 A NZ 201685A NZ 20168582 A NZ20168582 A NZ 20168582A NZ 201685 A NZ201685 A NZ 201685A
Authority
NZ
New Zealand
Prior art keywords
human
peptide
pharmaceutical compositions
proinsulin
insulin
Prior art date
Application number
NZ201685A
Inventor
R E Chance
B H Frank
J A Galloway
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NZ201685A publication Critical patent/NZ201685A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NZ201685A 1981-08-27 1982-08-24 Pharmaceutical compositions comprising human insulin,human c-peptide and human proinsulin NZ201685A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29671681A 1981-08-27 1981-08-27

Publications (1)

Publication Number Publication Date
NZ201685A true NZ201685A (en) 1985-09-13

Family

ID=23143244

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ201685A NZ201685A (en) 1981-08-27 1982-08-24 Pharmaceutical compositions comprising human insulin,human c-peptide and human proinsulin

Country Status (18)

Country Link
JP (1) JPS5846026A (en)
AU (1) AU551734B2 (en)
BE (1) BE894187A (en)
CA (1) CA1176159A (en)
CH (1) CH650680A5 (en)
DE (1) DE3232035A1 (en)
FR (1) FR2511868B1 (en)
GB (1) GB2104381B (en)
IL (1) IL66612A (en)
IT (1) IT1153183B (en)
LU (1) LU84357A1 (en)
MW (1) MW3982A1 (en)
NL (1) NL8203313A (en)
NZ (1) NZ201685A (en)
PH (1) PH18640A (en)
SE (1) SE8204872L (en)
ZA (1) ZA826160B (en)
ZW (1) ZW17682A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652548A (en) * 1981-08-27 1987-03-24 Eli Lilly And Company Pharmaceutical formulations comprising human insulin, human C-peptide, and human proinsulin
DE3326473A1 (en) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt PHARMACEUTICAL AGENT FOR TREATING THE DIABETES MELLITUS
JPS62222379A (en) * 1986-03-25 1987-09-30 Mutoh Ind Ltd Method and device for processing hidden line and hidden surface in computer graphics
US9389582B2 (en) 2014-06-02 2016-07-12 Lexmark International, Inc. Replaceable unit for an image forming device having magnets of varying angular offset for toner level sensing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
CH330318A (en) * 1953-09-08 1958-05-31 British Drug Houses Ltd Process for the production of an insulin preparation with an extended duration of action

Also Published As

Publication number Publication date
LU84357A1 (en) 1983-02-28
AU8759782A (en) 1983-03-03
BE894187A (en) 1983-02-24
PH18640A (en) 1985-08-23
MW3982A1 (en) 1984-06-13
AU551734B2 (en) 1986-05-08
ZW17682A1 (en) 1982-11-24
FR2511868B1 (en) 1986-05-09
SE8204872D0 (en) 1982-08-25
ZA826160B (en) 1984-04-25
IL66612A (en) 1985-11-29
NL8203313A (en) 1983-03-16
CA1176159A (en) 1984-10-16
JPS5846026A (en) 1983-03-17
FR2511868A1 (en) 1983-03-04
IT8223018A0 (en) 1982-08-27
IT1153183B (en) 1987-01-14
SE8204872L (en) 1983-02-28
GB2104381A (en) 1983-03-09
GB2104381B (en) 1984-12-05
DE3232035A1 (en) 1983-03-10
CH650680A5 (en) 1985-08-15

Similar Documents

Publication Publication Date Title
AU7914581A (en) Human proinsulin, insulin, preparation thereof
IL79887A0 (en) Human insulin analogues,their preparation and pharmaceutical compositions containing them
GB2105191B (en) Pharmaceutical formulations comprising human insulin and human proinsulin
GB2104382B (en) Pharmaceutical formulations comprising human insulin and human c-peptide
NZ208669A (en) Human calcitonin 2, and pharmaceutical compositions
NZ201685A (en) Pharmaceutical compositions comprising human insulin,human c-peptide and human proinsulin
GB2104380B (en) Human proinsulin pharmaceutical formulations
IE822063L (en) Insulin, proinsulin and c-peptide formulations
ZA854330B (en) Insulin formulations,processes for their preparation and their use
IE822065L (en) Insulin and proinsulin formulations
JO1238B1 (en) pharmaceutical formulations comprising human insulin ,human c-peptide ,and human proinsuline
JPS57209227A (en) Insulin medicine and manufacture
IE812104L (en) Novel insulin formulations based on human insulin
JO1209B1 (en) Pharmaceutical formulations comprising human insulin and human proinsulin.